Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | MRNA | BMY | AMGN | GILD |
| Company | Alnylam Pharmaceuticals | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 147.35 | 104.46 | 49.16 | 272.14 | 67.09 |
| High | 150.27 | 108.21 | 49.47 | 274.48 | 67.68 |
| Low | 145.04 | 103.48 | 48.96 | 271.05 | 67.00 |
| Last | 146.07 | 107.89 | 48.99 | 273.54 | 67.03 |
| Change | +0.28 | +3.43 | -0.15 | +1.63 | +0.08 |
| % Change | +0.19% | +3.28% | -0.31% | +0.60% | +0.12% |
| Volume | 543,700 | 2,435,200 | 9,153,200 | 2,493,300 | 5,240,200 |
| 20-Day Average Volume | 506,715 | 3,264,185 | 10,953,850 | 2,216,505 | 6,335,325 |
| Previous Close | 145.79 | 104.46 | 49.14 | 271.91 | 66.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 150.11 | 105.15 | 50.55 | 271.99 | 69.34 |
| 20-Day Raw Stochastic | 16.22% | 57.65% | 20.04% | 46.12% | 14.18% |
| 20-Day Relative Strength | 40.88% | 55.49% | 41.71% | 48.69% | 32.82% |
| Weighted Alpha | -28.56 | -9.49 | -25.74 | +11.45 | -20.86 |
| Today's Opinion | 100% Sell | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 72% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 72% Buy | 24% Sell | 8% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.44% since 04/16/24 | +3.95% since 04/16/24 | +1.51% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 |
| Low | 143.50 on 04/19/24 | 99.30 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 150.27 on 04/23/24 | 108.21 on 04/23/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -0.30% since 03/22/24 | +2.33% since 03/22/24 | -5.66% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 |
| Low | 143.50 on 04/19/24 | 97.00 on 04/03/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 159.34 on 04/09/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -23.00% since 01/23/24 | +5.86% since 01/23/24 | -2.25% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 |
| Low | 143.50 on 04/19/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 191.72 on 01/24/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | -9.83% since 10/23/23 | +37.19% since 10/23/23 | -12.52% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 |
| Low | 143.50 on 04/19/24 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 |
| High | 199.38 on 01/09/24 | 115.97 on 01/08/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,361,664 | 39,995,644 | 99,594,944 | 145,845,984 | 83,357,904 |
| Shares Outstanding, K | 125,946 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 1,828,290,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -440,240,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 439,720,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -137,870,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 0.39 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 02/15/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.52 | 14.42 | 9.93 |